Literature DB >> 20304326

The prevalence of neuropsychiatric disorders in Sydenham's chorea.

Keith R Ridel1, Tara D Lipps, Donald L Gilbert.   

Abstract

Sydenham's chorea is a rare movement disorder associated with streptococcal infection. The co-occurrence of neuropsychiatric symptoms has raised the question of whether streptococcal infection could trigger these symptoms without chorea. This study evaluated the prevalence of behavioral diagnoses before, during, and after the onset of chorea in a cohort of children with a history of Sydenham's chorea for whom demographic and clinical data were available. In all, 28 Sydenham's chorea patients were evaluated, with a mean age of 10.3 years. Retrospective analysis was performed for subject demographics, streptococcal titers, and presence of arthritis and carditis. Structured diagnostic interviews were performed on 14 available patients and parents. Streptococcal titers and duration of treatment for chorea were compared between groups. The prevalence of attention deficit hyperactivity disorder before and after chorea was 30 and 37%, respectively. The proportion of children meeting combined, subthreshold, and suprathreshold criteria before, during, and after Sydenham's chorea was 71, 79, and 79% for anxiety and 19, 69, and 44% for depression. Streptococcal antibody titers and duration of treatment did not correlate with attention deficit hyperactivity disorder, depression, or anxiety disorders. During and after the diagnosis of Sydenham's chorea, clinicians should be vigilant for signs and symptoms of anxiety, depression, and attention deficit hyperactivity disorder. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304326     DOI: 10.1016/j.pediatrneurol.2009.12.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

2.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

3.  Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment.

Authors:  Claire Gregorowski; Christine Lochner; Lindi Martin; Candice Simmons; Martin Kidd; Kathleen Walker; Jo M Wilmshurst; Soraya Seedat
Journal:  Metab Brain Dis       Date:  2015-05-19       Impact factor: 3.584

4.  Clinical and Neuroimaging Findings of Sydenham's Chorea.

Authors:  Arzu Ekici; Ayten Yakut; Sevgi Yimenicioglu; Kursat Bora Carman; Suzan Saylısoy
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

5.  Antibiotic treatment attenuates behavioral and neurochemical changes induced by exposure of rats to group a streptococcal antigen.

Authors:  Dafna Lotan; Madeleine Cunningham; Daphna Joel
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

6.  Language Impairment in Adolescents with Sydenham Chorea.

Authors:  J Gordon Millichap
Journal:  Pediatr Neurol Briefs       Date:  2015-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.